Depending on how long it lasts, the dockworkers strike that hit all 14 ports on the U.S. East Coast and along the Gulf Oct. 1 could literally unload a world of hurt to patients and the biopharma/med-tech industries, as it will impact both U.S. imports and exports of life-saving drugs and technologies.
Mari Serebrov is a biopharma writer and author, known for her contributions to Bioworld co. With a focus on national news in the United States, Mari covers a wide range of topics in the biopharmaceutical industry, including FDA regulations, drug launches, healthcare policy, and scientific advancements. Her expertise and insightful writing provide readers with valuable insights into the pharmaceutical landscape.